The AI revolution is rewriting the rules of drug development—slashing costs, accelerating timelines, and boosting success rates in an industry where only 9.6% of candidates reach the market. In this episode, we dissect how AI is transforming every phase of R&D, from target discovery to clinical trials, and why 91% of pharma executives now see AI as a strategic imperative. 

Key Discussion Points 

• From $2.6B to $70B in Savings
• Breakthrough Science
• Clinical Trials Reimagined
• The Make-or-Break Challenges

Real-World Impact: 

Explore how AI-native pharma companies achieve higher Phase 1 success rates and why 75% of industry leaders are already implementing AI—while laggards risk irrelevance. 

Who Should Listen? 

R&D heads, C-suite executives, and digital transformation leaders seeking to: 

• Prioritize high-ROI AI use cases
• Build vs. partner decisions for AI capabilities
• Navigate the tightrope between innovation and compliance

Tune in to future-proof your drug development pipeline—where AI isn’t just a tool, but your competitive edge. 

Resources:

Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB

Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/

Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0

Website: https://respa.com

and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!

#Pharma40 #DigitalSupplyChain #AIinPharma #IoT #Robotics #DigitalTransformation #SupplyChainInnovation #Podcast #ArtificialIntelligence #AI #PharmaceuticalIndustry #Innovation #Pharma